A new spin out company from the Medical Research Council’s Laboratory of Molecular Biology in Cambridge UK was announced this week. Bicycle Therapeutics is a new biotechnology company developing a novel technology platform for the creation of a new class of therapeutic entity which combines the most desirable features of small molecules and biologics.
23 October, 2009
ELRIG (The European Laboratory Robotic Interest Group) has a mission to give back to the Industry whenever they can and to encourage the growth of Innovative Technology. It was therefore very appropriate that they agreed to Sponsor the Technobotts in their venture to enter the RoboCup 2010 in Singapore.
22 October, 2009
Dr Leroy Hood-led venture has secured $30 million Series A financing from InterWest Partners, Wellcome Trust and dievini.
15 October, 2009
Olesoxime in ongoing pivotal efficacy study for amyotrophic lateral sclerosis.
08 October, 2009
BioFocus has recently launched its new microsite, www.SilenceSelect.com, which is dedicated to the SilenceSelect® and FLeXSelect® adenoviral technology.
08 October, 2009
Sanofi-aventis announced recently that it has signed a binding agreement for the acquisition of Fovea Pharmaceuticals SA (‘Fovea‘), a privately held French research and development biopharmaceutical company, focused on ocular diseases.
05 October, 2009
Multi-disciplinary healthcare giant Abbott Laboratories has fought off competition from Nycomed to secure the $6.6 billion acquisition of Solvay's pharmaceutical business.
02 October, 2009